Atlas Trials

A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture

Clinical trial NCT05060406 · UNKNOWN

Trial details

NCT number
NCT05060406
Sponsor
Luye Pharma Group Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Postmenopausal Osteoporosis
Start date
2019-06-30
Primary completion
2021-09-30
Enrollment
448

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.